Summary
The single-strand conformational polymorphism (SSCP) method was used to look for mutations in the 3’ half of exon 4 of the low-density lipoprotein receptor gene in patients with familial hypercholesterolaemia (FH). One set of conditions were found which allowed the detection of four of the mutations that have previously been reported in this part of the gene and detected in patients in the United Kingdom: the 3-bp deletion (del Gly197) the 2-bp deletion (STOP 216), the Asp206→Glu mutation and the Cys210→STOP. The method was used to screen 50 patients with definite or probable FH from London. Two were identified who were carriers of the 3-bp deletion of Gly197, one who was a carrier of the ASp206→Glu mutation and one who was a carrier of a novel mutation that alters Asp200→Gly. This mutation creates a cutting site for the restriction enzyme MspI. In a further sample of 200 patients from London with FH one additional apparently unrelated individual was detected who was a carrier of this defect. Thus in the sample of 50 patients, four (8%) had a mutation in this part of exon 4 that could be readily detected using the SSCP method, suggesting that this approach will be useful for rapid screening for mutations in patients with FH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- FH:
-
familial hypercholesterolaemia
- LDL:
-
low-density lipoprotein
- CAD:
-
coronary artery disease
- SSCP:
-
single-strand conformational polymorphism
- PCR:
-
polymerase chain reaction
References
Aalto-Setälä K, Gylling H, Miettinen T, Kontula K (1988) Identification of a deletion in the LDL receptor gene. A Finnish type of mutation. FEBS Lett 230:1, 2, 31–34
Benhamamouch S, Kusnierz J-P, Agnani G, Marzin D, Leierf JM, Fruchart JC, Clavey V (1988) Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay. Biochim Biophys Acta 1002:45–53
Betteridge DJ, Bhatnager D, Bing RF, Durrington PN, Evans GR, Flax H, Jay RH, Lewis-Barned N, Mann J, Matthews DR, Miller JP, Reckless JPD, Sturley R, Taylor KG (1992) Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. BMJ 304:1335–1338
Brown MS, Goldstein JL (1983) Familial hypercholesterolaemia. In: Stanbury JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited human disease, Macgraw Hill, New York, pp. 500–550
Cooper DN, Krawczak M (1990) The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 85:55–74
Cuthbert JL, East CE, Bilheimer DW, Lipsky PE (1986) Detection of familial hypercholesterolaemia by assaying functional low-density lipoprotein receptors on lymphocytes. New Engl J Med 314:879–883
Dunning AM, Houlston R, Frostegard J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S (1991) Genetic evidence that the putative receptor binding domain of apolipoprotein B [residues 3130 to 3630] is not the only region of the protein involved in interaction with the low density lipoprotein receptor. Biochim Biophys Acta 1096:231–237
Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG (1973) Hyperlipidaemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 52:1533–1543
Gudnason V, King-Underwood L, Seed M, Sun X-M, Soutar AK, Humphries SE (1993) Identification of recurrent and novel mutations in exon 4 of the receptor gene in patients with familial hypercholesterolaemia in the United Kingdom. Arteriosclerosis and Thrombosis 13:56–63
Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL (1987) Deletion in the gene for the low-density- lipoprotein receptor in a majority of French Canadians with familial hypercholesterolaemia. N Engl J Med 317:734–737
Hobbs HH, Russell DW, Brown MS, Goldstein JL (1990) The LDL receptor locus in familial hypercholesterolaemia: mutational analysis of a membrane protein. Ann Rev Genet 24:133–170
Humphries SE, Taylor R, Jeenah M, Dunning A, Horsthemke B, Seed M, Schuster H, Wolfram G (1989) Gene probes in the diagnosis of familial hypercholesterolaemia. Arteriosclerosis 9:59–65
Kessling AM, Seed M, Taylor R, Wynn V, Humphries SE (1990) Rising cholesterol levels in children with familial hypercholesterolaemia. Biomed Pharmacother 44:373–379
King-Underwood L, Gudnason V, Humphries S, Seed M, Patel D, Knight B, Soutar A (1991) Identification of the 664 proline to leucine mutation in the low density lipoprotein receptor in four unrelated patients with familial hypercholesterolaemia in the UK. Clin Genet 40:17–28
Koivisto PVI, Koivisto U-M, Miettinen TA, Kontula K (1992) {ayDiagnosis of heterozygous familial hypercholesterolaemia. DNA analysis complements clinical examination and analysis of serum lipid levels}. Arteriosclerosis and Thrombosis 12:584–592
Kwiterovich PO, Fredrickson DS, Levy RI (1974) Familial hypercholesterolaemia (one form of familial type II hyperlipoproteinaemia) — a study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest 53:1237–1249
Landsberger D, Meiner V, Reshef A, Levy Y, van der Westhuyzen DR, Coetzee GA, Leitersdorf E (1992) A nonsense mutation in the LDL receptor gene leads to familial hypercholesterolemia in the Druze sect. Am J Hum Genet 427:427–433
Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH (1990) Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85:1014–1023
Leitersdorf E, van der Westhuyzen DR, Coetzee GA, Hobbs HH (1989) Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest 84:954–961
Leonard JV, Whitelaw AGL, Wolff OH, Lloyd JK, Slack J (1977) Diagnosing familial hypercholesterolaemia in children by measuring serum cholesterol. BMJ I (6076):1566–1568
Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, Seftel HC, van der Westhuyzen DR, Jeenah MS, Gerhard A, Coetzee A, Leitersdorf E (1991) A common lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet 49:443–449
Merrill CR, Goldmann D, Sedmann SA, Ebert MH (1981) Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science 211:1437–1438
Montandon AJ, Green PM, Giannelli F, Bentley DR (1989) Direct detection of point mutations by mismatch analysis: application to haemophilia B. Nucleic Acids Res 17:3347–3358
Myers RM, Fischer SG, Lerman LS, Maniatis T (1985) Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res 13:3131–3145
Nagamine CM, Chan K, Lau Y-FC (1989) A PCR artifact: generation of heteroduplexes. Am J Hum Genet 45:337–339
Nora JJ, Loitscher RM, Spangler RD, Bilheimer DW (1985) Familial hypercholesterolaemics with “normal” cholesterol in obligatory heterozygotes. Am J Med Genet 22:585–591
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Schmitz G, Wolf D, Brunning T, Assman G (1987) Detection of LDL-binding sites on human white blood cells by flow cytometry. Clin Chem 33:2195–2202
Schuster H, Rauh G, Kormann B, Hepp T, Humphries S, Keller CH, Wolfram G, Zöllner N (1990) Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis and Thrombosis 10:577–581
Slack J (1969) Risks of ischaemic heart disease in familial hyperlipoproteinaemic states. Lancet II:1380–1382
Sun X-M, Webb JC, Gudnason V, Humphries S, Seed M, Thompson GR, Knight B, Soutar AK (1992) Characterisation of deletions in the LDL receptor gene in patients with familial hypercholesterolaemia in the United Kingdom. Arteriosclerosis and Thrombosis 12:767–770
Top B, Kopleman BPC, Gevers Leuven JA, Havekes LM, Frants RR (1990) Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolaemic patients: presence of a common 4kb deletion. Atherosclerosis 83:127–136
Top B, Uitterlinden AG, van der Zee A, Kastelein JJP, Gevers Leuven JA, Havekes LM, Frants RR (1992) Absence of mutations in the promoter region of the low density lipoprotein receptor gene in a large number of familial hypercholesterolaemia patients as revealed by denaturing gradient gel electrophoresis. Hum Genet 89:561–565
Tybærg-Hansen A, Gallagher J, Vincent J, Houlston R, Talmud P, Dunning AM, Seed M, Hamsten A, Humphries SE, Myant NB (1990) Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis 80:235–242
Tyroler HA (1985) Lowering blood cholesterol to prevent heart disease. JAMA 253:2080–2086
Webb JC, Sun X-N, Patel DD, McCarthy SN, Knight BL, Soutar AK (1992) Characterization of the two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolaemia. J Lipid Res 33:689–698
Yamamoto T, Davis LG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW (1984) The human LDL-receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39:27–38
Author information
Authors and Affiliations
Additional information
Dedicated to Prof Dr. N. Zöllner on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Gudnason, V., Mak, YT., Betteridge, J. et al. Use of the single-strand conformational polymorphism method to detect recurrent and novel mutations in the low-density lipoprotein repeptor gene in patients with familial hypercholesterolaemia: detection of a novel mutation Asp200 → Gly. Clin Investig 71, 331–337 (1993). https://doi.org/10.1007/BF00184738
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00184738